AzTrials
AzTrials

Osteo Arthritis Knee and HipPARTICIPATENCT07202286

Comparing Physician and Artificial Intelligence Chatbot Responses to Frequently Asked Questions From Osteoarthritis Patients

An observational study of Osteo Arthritis Knee and Hip and Artificial Intelligence (AI), run by Canisius-Wilhelmina Hospital at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to compare the patient acceptability (preference, length, and difficulty) and accuracy of Chat-Generative Pre-Trained Transformer (ChatGPT) responses to questions from people with osteoarthritis (OA) with physician responses. Read more about this study

Who is it for?
Any age
How many people
286 participants
Where
1 siteNetherlands
Study dates
22 May 2024to 5 Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: There were two groups of participants: 1) a panel of people with OA evaluating the preference, length, and difficulty, and 2) a panel of experts in the field of OA evaluating the accuracy of the responses

Who may be able to join

  • all individuals visiting the Department of Orthopedics in the Canisius Wilhelmina Hospital, a district general hospital in Nijmegen, The Netherlands, diagnosed with knee or hip OA between March 2023 and March 2024

Who cannot join

  • partly completion of the questionnaire

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Canisius Wilhelmina Hospital

    Nijmegen

Other trials in Netherlands

About this study

Official title: Comparing Physician and Artificial Intelligence Chatbot Responses to Frequently Asked Questions From Osteoarthritis Patients: a Prospective Cross-sectional Study

This study aimed to compare the patient acceptability (preference, length, and difficulty) and accuracy of Chat-Generative Pre-Trained Transformer (ChatGPT) responses to questions from people with osteoarthritis (OA) with physician responses.

Read the detailed description

This was a cross-sectional study where participants were invited by e-mail to participate in the questionnaire to compare Chatbot responses to physician responses.

Keywords
chatGPT, Osteoarthritis, Acceptability, Accuracy, Artificial Intelligence, Cross-sectional
Medical subject headings
Osteoarthritis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Preferred response

    Binary outcome, chatbot or physician response. This was an average based on the preferences on the 7 FAQs.

    Measured: From invitation until the end of the study at two weeks

Secondary outcomes (3)
  1. Rating of length

    Rating of both responses (chatbot and physician response) included 'too short', 'good', and 'too long'.

    Measured: From invitation until the end of the study at two weeks

  2. Rating of difficulty

    Rating of difficulty included 'too easy', 'good', and 'too difficult' for both responses.

    Measured: From invitation until the end of the study at two weeks

  3. Accuracy

    Accuracy of the responses included the options 'Completely incorrect,' 'partly incorrect, ' 'approximately equally correct and incorrect,' 'mostly correct,' 'completely correct'.

    Measured: From invitation until the end of the study at two weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2025
  2. Study start22 May 2024
  3. Primary completion5 Jun 2024
  4. Study completion5 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
286 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07202286
Sponsor's protocol ID
075-2023
Acronym
PARTICIPATE
Status last verified
Oct 2025
First submitted
30 Sep 2025
Last updated
6 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The dataset supporting the conclusions of this study is available from the corresponding author upon reasonable request.

Questions about this trial

What is this clinical trial studying?

An observational study of Osteo Arthritis Knee and Hip and Artificial Intelligence (AI), run by Canisius-Wilhelmina Hospital at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Preferred response (time frame: From invitation until the end of the study at two weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in